Shire PLC Company Profile (LON:SHP)

About Shire PLC (LON:SHP)

Shire PLC logoShire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Its Hematology products include ADVATE (Antihemophilic Factor (Recombinant)), ADYNOVATE/ADYNOVI (Antihemophilic Factor (Recombinant), PEGylated)), RIXUBIS (Coagulation Factor IX (Recombinant)), VONVENDI (von Willebrand factor (Recombinant)) and FEIBA (Anti-Inhibitor Coagulant Complex). Its Genetic Diseases products include CINRYZE (C1 esterase inhibitor (human)), FIRAZYR (icatibant), ELAPRASE (idursulfase), REPLAGAL (agalsidase alfa) and VPRIV (velaglucerase alfa).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals - NEC
  • Sub-Industry: N/A
  • Symbol: LON:SHP
  • CUSIP: N/A
  • Web: www.shire.com
Capitalization:
  • Market Cap: £40.87 billion
  • Outstanding Shares: 904,099,000
Average Prices:
  • 50 Day Moving Avg: GBX 4,566.72
  • 200 Day Moving Avg: GBX 4,619
  • 52 Week Range: GBX 2,707.19 - GBX 5,377
P/E:
  • Trailing P/E Ratio: 139.08
  • P/E Growth: 0.91
Sales & Book Value:
  • Annual Revenue: £13.26 billion
  • Price / Sales: 3.08
  • Book Value: GBX 32.89 per share
  • Price / Book: 1.37
Dividend:
  • Dividend Yield: 0.5%
Profitability:
  • EBIDTA: £5.31 billion
  • Net Margins: 9.95%
  • Return on Equity: 4.85%
  • Return on Assets: 2.14%
Misc:
  • Average Volume: 2.38 million shs.
 

Frequently Asked Questions for Shire PLC (LON:SHP)

What is Shire PLC's stock symbol?

Shire PLC trades on the London Stock Exchange (LON) under the ticker symbol "SHP."

How often does Shire PLC pay dividends? What is the dividend yield for Shire PLC?

Shire PLC declared a dividend on Thursday, February 16th. Shareholders of record on Thursday, March 9th will be given a dividend of GBX 20.64 per share on Tuesday, April 25th. This represents a dividend yield of 0.43%. The ex-dividend date of this dividend is Thursday, March 9th. This is a boost from Shire PLC's previous dividend of $3.51. The official announcement can be viewed at this link. View Shire PLC's Dividend History.

When will Shire PLC make its next earnings announcement?

Shire PLC is scheduled to release their next quarterly earnings announcement on Thursday, August, 3rd 2017. View Earnings Estimates for Shire PLC.

Where is Shire PLC's stock going? Where will Shire PLC's stock price be in 2017?

17 equities research analysts have issued twelve-month price objectives for Shire PLC's stock. Their predictions range from GBX 4,450 to GBX 6,970. On average, they expect Shire PLC's stock price to reach GBX 6,005.60 in the next twelve months. View Analyst Ratings for Shire PLC.

Who are some of Shire PLC's key competitors?

Who are Shire PLC's key executives?

Shire PLC's management team includes the folowing people:

  • Flemming Ornskov M.D., Chief Executive Officer, Executive Director
  • Jeffrey Poulton, Chief Financial Officer, Executive Director
  • William Mordan, General Counsel, Company Secretary
  • Perry Sternberg, Head - U.S. Commercial
  • Kim Stratton, Head - International Commercial
  • Philip J. Vickers, Head - Research and Development
  • Matthew Walker, Head - Technical Operations
  • Susan Saltzbart Kilsby, Independent Non-Executive Chairman of the Board
  • Olivier Bohuon, Non-Executive Director
  • Ian T. Clark, Non-Executive Director

How do I buy Shire PLC stock?

Shares of Shire PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Shire PLC's stock price today?

One share of Shire PLC stock can currently be purchased for approximately GBX 4,520.


MarketBeat Community Rating for Shire PLC (LON SHP)
Community Ranking:  4.3 out of 5 (   )
Outperform Votes:  1,008 (Vote Outperform)
Underperform Votes:  168 (Vote Underperform)
Total Votes:  1,176
MarketBeat's community ratings are surveys of what our community members think about Shire PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Shire PLC (LON:SHP) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 14 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.88)
Consensus Price Target: GBX 6,005.60

Analysts' Ratings History for Shire PLC (LON:SHP)
Show:
DateFirmActionRatingPrice TargetDetails
6/28/2017Liberum CapitalReiterated RatingHoldGBX 4,900View Rating Details
6/28/2017Goldman Sachs Group, Inc. (The)Lower Price TargetConviction-BuyGBX 6,800 -> GBX 6,400View Rating Details
6/27/2017Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
6/27/2017Credit Suisse GroupReiterated RatingOutperformGBX 5,350View Rating Details
6/27/2017Barclays PLCReiterated RatingOverweightGBX 6,300View Rating Details
6/27/2017Deutsche Bank AGReiterated RatingBuyGBX 6,000View Rating Details
6/27/2017J P Morgan Chase & CoReiterated RatingOverweightView Rating Details
6/22/2017Citigroup Inc.Reiterated RatingBuyGBX 6,500View Rating Details
6/21/2017Shore CapitalReiterated RatingBuyView Rating Details
6/9/2017Jefferies Group LLCLower Price TargetBuyGBX 6,400 -> GBX 5,600View Rating Details
6/8/2017Berenberg BankLower Price TargetBuyGBX 6,100 -> GBX 6,000View Rating Details
5/19/2017HSBC Holdings plcDowngradeReduceGBX 4,550 -> GBX 4,450View Rating Details
4/3/2017BNP ParibasReiterated RatingOutperformGBX 5,900View Rating Details
3/23/2017Societe GeneraleReiterated RatingBuyGBX 6,200View Rating Details
1/9/2017Bryan, Garnier & CoReiterated RatingBuyGBX 6,800View Rating Details
11/7/2016AlphaValueReiterated RatingBuyGBX 6,714View Rating Details
11/3/2016Bank of America CorporationReiterated RatingBuyGBX 6,970View Rating Details
6/3/2016Morgan StanleyReiterated RatingOverweightGBX 5,600View Rating Details
3/15/2016Sanford C. BernsteinReiterated RatingOutperformGBX 5,000View Rating Details
1/12/2016S&P Equity ResearchReiterated RatingBuyView Rating Details
12/3/2015InvestecDowngradeSellView Rating Details
11/3/2015Kepler Capital MarketsLower Price TargetBuyGBX 6,000 -> GBX 5,900View Rating Details
(Data available from 6/28/2015 forward)

Earnings

Earnings History for Shire PLC (LON:SHP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Shire PLC (LON:SHP)
Current Year EPS Consensus Estimate: $5.01 EPS

Dividends

Dividend History by Quarter for Shire PLC (LON SHP)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2017GBX 20.640.43%3/9/20173/9/20174/25/2017
8/2/2016GBX 3.510.07%9/8/20169/8/201610/7/2016
2/11/2016GBX 15.320.44%3/10/20163/10/20164/12/2016
7/23/2015GBX 2.690.05%9/3/20159/3/201510/2/2015
7/18/2014GBX 2.240.04%9/3/20149/3/201410/3/2014
2/13/2014GBX 10.210.31%3/5/20143/5/20144/8/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Shire PLC (LON:SHP)
Insider Trades by Quarter for Shire PLC (LON:SHP)
Insider Trades by Quarter for Shire PLC (LON:SHP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/31/2017William BurnsInsiderBuy136GBX 4,742£6,449.12
12/16/2016Olivier BohuonInsiderBuy141GBX 4,528£6,384.48
9/30/2016Dominic BlakemoreInsiderBuy133GBX 5,010£6,663.30
6/30/2016Bohuon,OlivierInsiderBuy134GBX 4,463£5,980.42
3/31/2016Bohuon,OlivierInsiderBuy133GBX 3,908£5,197.64
2/15/2016Bohuon,OlivierInsiderBuy1,000GBX 3,552£35,520
2/12/2016Burns,WilliamInsiderBuy1,250GBX 3,563£44,537.50
12/18/2015Burns,WilliamInsiderBuy156GBX 4,457£6,952.92
9/30/2015Blakemore ,DominicInsiderBuy129GBX 4,498£5,802.42
6/30/2015Kappler,David JInsiderBuy126GBX 51.05GBX 6,432.30
3/31/2015Susan KilsbyInsiderBuy375GBX 5,327£19,976.25
12/19/2014Steven GillisInsiderBuy228GBX 4,654£10,611.12
10/30/2014Steven GillisInsiderBuy381GBX 4,098£15,613.38
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Shire PLC (LON:SHP)
Latest Headlines for Shire PLC (LON:SHP)
Source:
DateHeadline
americanbankingnews.com logoShire PLC (SHP) Given Buy Rating at Citigroup Inc.
www.americanbankingnews.com - June 25 at 10:02 AM
nasdaq.com logoShire Says EMA Validates Veyvondi MAA For Treatment Of Von Willebrand Disease
www.nasdaq.com - June 22 at 1:31 PM
finance.yahoo.com logoShire (SHPG) Receives MAA Validation for Veyvondi by EMA
finance.yahoo.com - June 22 at 1:31 PM
rttnews.com logoShire : FDA Approves Mydayis, New Once-Daily Option For ADHD Symptom Control
www.rttnews.com - June 21 at 5:20 AM
finance.yahoo.com logoShire plc: U.S. FDA Approves Mydayis (Mixed Salts of a Single-Entity Amphetamine Product) - A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older
finance.yahoo.com - June 21 at 5:20 AM
americanbankingnews.com logoShire PLC's (SHP) Overweight Rating Reaffirmed at J P Morgan Chase & Co
www.americanbankingnews.com - June 19 at 10:08 PM
americanbankingnews.com logoShire PLC (SHP) Given New GBX 6,000 Price Target at Deutsche Bank AG
www.americanbankingnews.com - June 18 at 10:20 PM
americanbankingnews.com logoShire PLC (SHP) Given Hold Rating at Liberum Capital
www.americanbankingnews.com - June 18 at 10:46 AM
americanbankingnews.com logoShire PLC (SHP) Given "Overweight" Rating at Barclays PLC
www.americanbankingnews.com - June 11 at 9:38 AM
americanbankingnews.com logoJefferies Group LLC Trims Shire PLC (SHP) Target Price to GBX 5,600
www.americanbankingnews.com - June 11 at 12:26 AM
americanbankingnews.com logoShire PLC (SHP) PT Lowered to GBX 6,000 at Berenberg Bank
www.americanbankingnews.com - June 8 at 6:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shire plc - SHPG
finance.yahoo.com - June 7 at 7:40 PM
americanbankingnews.com logoShire PLC (SHP) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - June 5 at 9:15 AM
investopedia.com logoBrexit Winners: Why JPMorgan Is Buying UK Stocks
www.investopedia.com - June 3 at 12:20 AM
americanbankingnews.com logoShire PLC (SHP) Lowered to "Hold" at Liberum Capital
www.americanbankingnews.com - June 1 at 1:40 PM
americanbankingnews.com logoShire PLC (SHP) Given "Overweight" Rating at JPMorgan Chase & Co.
www.americanbankingnews.com - May 28 at 3:56 PM
americanbankingnews.com logoDeutsche Bank AG Reiterates Buy Rating for Shire PLC (SHP)
www.americanbankingnews.com - May 28 at 3:56 PM
americanbankingnews.com logoShire PLC's (SHP) Overweight Rating Reiterated at Barclays PLC
www.americanbankingnews.com - May 28 at 2:38 PM
americanbankingnews.com logoShire PLC (SHP) Lowered to Reduce at HSBC Holdings plc
www.americanbankingnews.com - May 28 at 2:02 PM
americanbankingnews.com logoLiberum Capital Reiterates Buy Rating for Shire PLC (SHP)
www.americanbankingnews.com - May 26 at 6:38 PM
americanbankingnews.com logoShire PLC's (SHP) "Buy" Rating Reiterated at Citigroup Inc
www.americanbankingnews.com - May 18 at 10:20 PM
nasdaq.com logoShire's swelling disorder drug moves closer to U.S. approval - Nasdaq
www.nasdaq.com - May 18 at 1:08 PM
finance.yahoo.com logoShire's Investigational Treatment Lanadelumab Reduces Hereditary Angioedema Monthly Attack Rate by 87% Versus Placebo in Phase 3 26-week Pivotal Trial
finance.yahoo.com - May 18 at 1:08 PM
finance.yahoo.com logoShire ADRs jump almost 7% premarket after positive trial of Angioedema treatment
finance.yahoo.com - May 18 at 1:08 PM
finance.yahoo.com logoThe Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis
finance.yahoo.com - May 18 at 1:08 PM
finance.yahoo.com logo​Shire gains $2B in market cap as rare disease drug aces late-stage trial
finance.yahoo.com - May 18 at 1:08 PM
finance.yahoo.com logoShire's swelling disorder drug moves closer to U.S. approval
finance.yahoo.com - May 18 at 1:08 PM
finance.yahoo.com logoShire Continues 20-Year Commitment to ADHD with New Research at 2017 Annual Meeting of American Psychiatric Association
finance.yahoo.com - May 16 at 9:16 AM
finance.yahoo.com logoShire Plc – Value Analysis (LONDON:SHP) : May 15, 2017
finance.yahoo.com - May 15 at 7:02 PM
americanbankingnews.com logoDeutsche Bank AG Cuts Shire PLC (SHP) Price Target to GBX 6,100
www.americanbankingnews.com - May 14 at 11:30 PM
americanbankingnews.com logoShire PLC's (SHP) "Buy" Rating Reaffirmed at Berenberg Bank
www.americanbankingnews.com - May 14 at 2:08 PM
finance.yahoo.com logoShire Plc breached its 50 day moving average in a Bullish Manner : SHP-GB : May 12, 2017
finance.yahoo.com - May 13 at 12:28 AM
americanbankingnews.com logoShire PLC (SHP) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - May 9 at 9:24 AM
americanbankingnews.com logoShire PLC (SHP) Rating Reiterated by Citigroup Inc
www.americanbankingnews.com - May 7 at 7:34 PM
finance.yahoo.com logoEdited Transcript of SHP.L earnings conference call or presentation 2-May-17 1:00pm GMT
finance.yahoo.com - May 3 at 10:54 AM
americanbankingnews.com logoShire PLC (SHP) Rating Reiterated by JPMorgan Chase & Co.
www.americanbankingnews.com - May 3 at 7:06 AM
thestreet.com logoShire Stock Lifted By First-Quarter Earnings Beat - TheStreet.com
www.thestreet.com - May 2 at 5:38 PM
nasdaq.com logoUK Stocks-Factors to watch on May 2
www.nasdaq.com - May 2 at 9:08 AM
marketwatch.com logoShire profit drops 11%, revenue more than doubles
www.marketwatch.com - May 2 at 9:08 AM
finance.yahoo.com logoInvestor Network: Shire PLC to Host Earnings Call
finance.yahoo.com - May 2 at 9:08 AM
finance.yahoo.com logoShire Stock Lifted By First-Quarter Earnings Beat
finance.yahoo.com - May 2 at 9:08 AM
finance.yahoo.com logoDurham CEO on deal with Shire valued at up to $535M
finance.yahoo.com - May 2 at 9:08 AM
finance.yahoo.com logo[$$] Shire Profit Pressured by Baxalta Takeover Costs
finance.yahoo.com - May 2 at 9:08 AM
americanbankingnews.com logoShire PLC (SHP) Earns "Conviction-Buy" Rating from Goldman Sachs Group Inc
www.americanbankingnews.com - April 30 at 11:28 AM
americanbankingnews.com logoShire PLC (SHP) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - April 30 at 9:48 AM
americanbankingnews.com logoShire PLC's (SHP) "Buy" Rating Reaffirmed at Shore Capital
www.americanbankingnews.com - April 28 at 2:57 AM
americanbankingnews.com logoShire PLC (SHP) Given "Outperform" Rating at Royal Bank of Canada
www.americanbankingnews.com - April 27 at 6:58 AM
americanbankingnews.com logoShire PLC (SHP) Given "Outperform" Rating at Credit Suisse Group AG
www.americanbankingnews.com - April 25 at 2:04 AM
americanbankingnews.com logoShire PLC (SHP) Given "Buy" Rating at Shore Capital
www.americanbankingnews.com - April 24 at 6:36 AM
americanbankingnews.com logoShire PLC (SHP) Earns Outperform Rating from Credit Suisse Group AG
www.americanbankingnews.com - April 23 at 8:40 PM

Social

Social activity is not available for this stock.

Chart

Shire PLC (SHP) Chart for Wednesday, June, 28, 2017

This page was last updated on 6/28/2017 by MarketBeat.com Staff